Detalhe da pesquisa
1.
VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.
J Am Soc Nephrol
; 35(3): 311-320, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261535
2.
Pathophysiology of Diet-Induced Acid Stress.
Int J Mol Sci
; 25(4)2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38397012
3.
The mechanisms of alkali therapy in targeting renal diseases.
Biochem Soc Trans
; 51(1): 223-232, 2023 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36744634
4.
Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis.
Nephrol Dial Transplant
; 38(6): 1448-1458, 2023 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331426
5.
Metabolic Basis and Pathogenesis of Skeletal Muscle Dysfunction as Cause of Frailty in Chronic Kidney Disease.
Am J Nephrol
; 53(10): 740-752, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473450
6.
Factors Affecting the Decision to Initiate Dialysis: A National Survey of United States Nephrologists.
Am J Nephrol
; 53(10): 722-729, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477582
7.
Relationship between Metabolic Acidosis and Chronic Kidney Disease Progression across Racial and Ethnic Groups: An Observational, Retrospective Cohort Study.
Am J Nephrol
; 53(8-9): 603-613, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36349769
8.
Biomarkers of Covert Acid Stress in Patients with Chronic Kidney Disease: A Cross-Sectional Study.
Am J Nephrol
; 53(11-12): 794-805, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36642068
9.
Effects of veverimer on serum bicarbonate and physical function in diabetic patients with chronic kidney disease and metabolic acidosis: subgroup analysis from a randomized, controlled trial.
Nephrol Dial Transplant
; 37(7): 1302-1309, 2022 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34240198
10.
Effects of veverimer on serum bicarbonate and physical function in women with chronic kidney disease and metabolic acidosis: a subgroup analysis from a randomised, controlled trial.
BMC Nephrol
; 23(1): 82, 2022 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35216581
11.
Treatment of Chronic Kidney Disease-Related Metabolic Acidosis With Fruits and Vegetables Compared to NaHCO3 Yields More and Better Overall Health Outcomes and at Comparable Five-Year Cost.
J Ren Nutr
; 31(3): 239-247, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32952009
12.
Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease.
J Am Soc Nephrol
; 31(3): 469-482, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31988269
13.
A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial.
J Am Soc Nephrol
; 31(1): 161-174, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31848294
14.
Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension.
Lancet
; 394(10196): 396-406, 2019 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31248662
15.
Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.
Lancet
; 393(10179): 1417-1427, 2019 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30857647
16.
Novel dietary and pharmacologic approaches for acid-base modulation to preserve kidney function and manage uremia.
Curr Opin Nephrol Hypertens
; 29(1): 39-48, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31725012
17.
Urine citrate excretion identifies changes in acid retention as eGFR declines in patients with chronic kidney disease.
Am J Physiol Renal Physiol
; 317(2): F502-F511, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31215805
18.
Elevated serum anion gap in adults with moderate chronic kidney disease increases risk for progression to end-stage renal disease.
Am J Physiol Renal Physiol
; 316(6): F1244-F1253, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30908932
19.
Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis.
Kidney Int
; 95(5): 1190-1196, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30846270
20.
Clinical evidence that treatment of metabolic acidosis slows the progression of chronic kidney disease.
Curr Opin Nephrol Hypertens
; 28(3): 267-277, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30681417